Unilever To Buy GlaxoSmithKline's Horlicks Unit For $3.8 Billion

Unilever is to buy GlaxoSmithKline's Indian Horlicks nutrition business for around $3.8 billion, boosting the consumer goods group's position in a key emerging market. The deal, announced on Monday, marks a further step by drug maker GSK to streamline its business and follows a competitive auction in which Unilever saw off rival Nestle, as well as earlier interest from Coca-Cola. The transaction covers GSK's health food and drinks po...